Join our community of traders FOR FREE!

  • Learn
  • Improve yourself
  • Get Rewards
Learn More

Lilly Lifts Sales Outlook on GLP-1 Demand, Trims EPS

October 29, 2026 12:09 pm
Key Moments Eli Lilly raised its full-year revenue outlook to $91 billion-$92 billion after third-quarter sales and earnings exceeded analyst forecasts. Strong demand for Mounjaro and Zepbound fueled a 53% volume increase in the third quarter, while realized prices declined 15% globally. The company cut its adjusted profit guidance to $35.00-$36.00 per share due to […] Read more

Merck Posts Strong Q3 on Oncology, Vaccine Growth

October 29, 2026 12:05 pm
Key Moments Merck’s third-quarter revenue reached $18.1 billion, surpassing the $17.3 billion analyst consensus. Keytruda sales rose to $8.6 billion and Gardasil revenue climbed about 14% to just under $2 billion. The company raised its full-year revenue and adjusted earnings forecasts on the back of strong product performance. Third-Quarter Performance Exceeds Market Expectations By Michael […] Read more

Palantir Rises as JPMorgan Launches Bullish Coverage

October 29, 2026 12:03 pm
Key Moments: Palantir stock rose 0.8% in pre-market trading after JPMorgan began coverage with an Overweight rating and a $262 December 2027 price target. JPMorgan’s valuation hinges on strong free-cash-flow projections, including an estimated $11.7 billion in 2028 and a roughly 77% three-year compound annual growth rate. The upbeat initiation and Positive Catalyst Watch designation […] Read more

Chipotle Jumps on Strong Sales Trends, Upbeat Outlook

October 29, 2026 10:05 am
Key Moments Chipotle Mexican Grill (NYSE:CMG) surged 6.9% in pre-market trading to $30.71 following its third-quarter 2026 earnings release. Comparable restaurant sales increased 2.1%, beating expectations of roughly 1.5% and marking a third straight quarter of positive transaction growth. Despite an EPS miss of $0.02 versus consensus, upbeat Q4 guidance and record digital and loyalty […] Read more

Marvell Drops as Markets Weigh Potential Lumentum Buyout

October 29, 2026 9:50 am
Key Moments Marvell Technology stock is down 9.5% in pre-market trading following a report it is in advanced talks to buy Lumentum Holdings. The reported deal size relative to Marvell’s $3.92 billion cash balance is fueling concerns over equity and debt financing and potential earnings dilution. Weakness in the broader tech sector, driven by Alphabet’s […] Read more

Alphabet Drops as Search Lags Heavy Cloud and AI Spend

October 29, 2026 9:34 am
Key Moments Alphabet (NASDAQ: GOOG) shares dropped by more than 10% in premarket trading after third-quarter earnings came in below Wall Street forecasts. Google Cloud revenue jumped 103% to $30.7 billion, with operating income more than tripling to $11.1 billion and 18 product lines each generating over $1 billion annually. Heavy AI-driven capital expenditures of […] Read more

Shell Beats Q3 Estimates and Expands Share Buybacks

October 29, 2026 8:38 am
Key Moments Shell reported third-quarter net profit of $10.81 billion, surpassing analyst expectations of $10.33 billion. Refining margins climbed to a record $42 per barrel, up from $11.6 a year earlier and $24 in the prior quarter. The company increased its quarterly share buyback program to $5 billion from $3 billion. Profit Surges on Strong […] Read more

Options Market Eyes 12% Datadog Swing Ahead of Earnings

October 28, 2026 2:55 pm
Key Moments Options pricing points to a 12% move in Datadog Inc. Class A shares on Nov. 4 when earnings are released before the opening bell. Datadog has surpassed the options-implied move in four of its last eight earnings events. Recent earnings reactions have ranged from a 40.9% surge to an 8.4% decline relative to […] Read more

Options Market Eyes 3% Swing in McDonald’s Earnings

October 28, 2026 2:49 pm
Key Moments: Options prices signal an expected 3% move in McDonald’s Corp. (NYSE:MCD) stock around the November 4 pre-market earnings release. McDonald’s shares have exceeded the options-implied move in three of the last eight earnings events cited. Recent earnings reactions have ranged from a 6.8% gain to a 6.3% loss versus implied moves between 2.7% […] Read more

Trian Leads $1.4 Billion Take-Private Bid for Wendy’s

October 28, 2026 2:21 pm
Key Moments Trian Fund Management and partners have proposed taking Wendy’s private in a deal valuing the company at about $1.4 billion. The consortium’s all-cash offer of $7.35 per share represents roughly a 20% premium to Wendy’s most recent closing price. Wendy’s shares rose about 16% to $7.12 in premarket trading following disclosure of the […] Read more